UIC Transplant Pharmacotherapy Team retweeted
The expansion of kinase drug discovery: new targets, platforms and indications
nature.com/articles/s41573-0…
rdcu.be/58kHQSQ3Xcna
This new Review analyses the kinase therapeutic landscape, covering more than 2,100 kinase-targeting agents that have entered clinical development
UIC Transplant Pharmacotherapy Team retweeted
👴💪 La actividad física es clave para un envejecimiento saludable.
📢 Nueva serie de The Lancet Healthy Longevity sobre actividad física en mayores.
🏋️ Fuerza y equilibrio para preservar la autonomía y prevenir la dependencia.
🔗 thelancet.com/series-do/phys…
UIC Transplant Pharmacotherapy Team retweeted
#ASNKidney360 An 18-year-old developed KDIGO stage 3 AKI after minimal naproxen exposure. Pharmacogenetic testing revealed a CYP2C92/2 genotype associated with reduced NSAID metabolism, underscoring a potentially underrecognized contributor to NSAID-associated nephrotoxicity. kidney.pub/KID1431
UIC Transplant Pharmacotherapy Team retweeted
🚨 Editor’s Choice 🚨
"Alpha-gal syndrome: Unrecognized risks of a tick-bite-associated allergy in transplantation and cellular therapy," by Jacobs et al
buff.ly/9ZzgMyI
#AlphaGalSyndrome #Transplantation #CellularTherapy #Xenotransplantation
@jwjacobs12
UIC Transplant Pharmacotherapy Team retweeted
🚨 Editor’s Choice 🚨
"Viewpoint on donor-derived cell-free DNA: Context of use and clinical utility are key," by Budde at al
buff.ly/dT40qHN
#DonorDerivedCellFreeDNA #ddcfDNA #Transplantation
@louise_benning
UIC Transplant Pharmacotherapy Team retweeted
How much can physical function tell us about future health in CKD? A lower SPPB score was strongly associated with increased risks of heart failure and mortality, suggesting this quick assessment may help identify patients at highest risk, according to study in #ASNCJASN. kidney.pub/CJASN1219
A fresh approach considers waist circumference, rather than just weight and height, providing a more accurate classification than BMI
go.nature.com/4zR5xNW
UIC Transplant Pharmacotherapy Team retweeted
#Uterus #transplants in the U.S. show technique largely successful to achieve live birth | ow.ly/WCBk51017vR
#uterustransplant #transplantation
💡Interested in bioengineering? Join the next @CTRMS_Social webinar this Thursday, Nov. 12!
We'll be discussing 👉 Frontiers in Organ Engineering: Human Organoids and the Bioartificial Kidney
🗣️Speakers include Alice A. Tomei, David Lott, Rohan Paul, Shuvo Roy, and Hans Clevers
📅 Thursday, November 12 at 1 pm (ET)
Join here🔗 tinyurl.com/ybe2dyn5
#organoids #kidneydisease #transplantation #bioartificialkidney #transplanttwitter #medtwitter
UIC Transplant Pharmacotherapy Team retweeted
Finally, a global consensus on #ACLF criteria and severity !
It will help large-scale observational studies and better international clinical trials.
@EASLnews @AASLDtweets @APASLnews @alehlatam @Solda_Society
UIC Transplant Pharmacotherapy Team retweeted
Could terminal complement activation explain prolonged delayed graft function is addressed by Editorial fellow Arunkumar Sabbiah #TXPforAll #Transplantation #OpenAccess tinyurl.com/7usktjaw
UIC Transplant Pharmacotherapy Team retweeted
How do standard kidney transplant drugs affect donor and recipient leukocytes? This murine mismatch model explores their impact on immune cell behavior and may reveal new insights into transplant immunosuppression.#TXPforAll #Transplantation tinyurl.com/8jr6zxc8
UIC Transplant Pharmacotherapy Team retweeted
Injury, immune activity, inflammation: each test answers a different question. Christopher McCloskey, President of Eurofins Transplant Genomics, on where urinary CXCL9/10 fits alongside dd-cfDNA and gene expression testing.
🔗: brnw.ch/21x71pq
#Eurofins #Nephrology
UIC Transplant Pharmacotherapy Team retweeted
👏🏽 Excellent work, by @SLUTransplantRx Team, under leadership @MinaBenjaminMD | @drrushdafaruk | @AvaDelonai6124 📖 🫀🌟
➡️ Read more👇🏽
📢 Does a positive stress echo before kidney transplant predict who has a cardiac event afterward? In our study of 354 recipients, it didn't.
📈 58 patients (16.3%) had a positive pre-transplant stress echo. Over a mean of 54 months, 18.9% had MACE, but a positive stress echo was not associated with these events.
💡 Why? Cardiovascular risk in kidney failure is driven less by flow-limiting CAD and more by LV hypertrophy, myocardial fibrosis, diastolic dysfunction, arrhythmia, and volume overload. Ischemia testing doesn't capture most of these.
This fits with ISCHEMIA-CKD and the AHA's move away from routine screening of transplant candidates. Could the next step be to look beyond ischemia, toward myocardial phenotyping with strain, LA function, and RV function? 🫀
📄 Annals of Transplantation: annalsoftransplantation.com/…
#CardioTwitter #TransplantCardiology #EchoFirst #kidneytransplant
Congratulations to @spencerhobbsmed, @AvaDelonai6124, @BarbsMedJourney, @KristaLentine, and @MinaBenjaminMD for their work on this paper!
UIC Transplant Pharmacotherapy Team retweeted
So excited to see this published! Such a challenging clinical area after kidney transplant, recurrent IGA nephropathy. These authors do a great job summarizing the current state of the evidence. Thank you @AlJurdi for expertly spearheading this. @TransplantJrnl
Excited to share our article about how we treat recurrent IgAN after kidney transplant, published in @TransplantJrnl. A lot of new therapies that need to be translated to the transplant context.
shorturl.at/dusy9
CC @anuja_java Ayesha Malik @KottonNelson
UIC Transplant Pharmacotherapy Team retweeted
💬 Who should receive a liver graft for unresectable colorectal liver metastases?
In this letter and reply, Acar and Cillo et al discuss prognostic factors, survival benefit, donor safety, and access to transplantation.
✉️ journals.lww.com/lt/fulltext…
↪️ journals.lww.com/lt/fulltext…
UIC Transplant Pharmacotherapy Team retweeted
Norovirus in transplant recipients: what actually works is discussed in this scoping review paper by Maung Myint et al. #TXPforAll #Transplantation #norovirus #OpenAccess tinyurl.com/3ahn3byx
UIC Transplant Pharmacotherapy Team retweeted
#ASNJASN #Perspective: IgA vasculitis nephritis can range from mild urinary abnormalities to kidney failure, and current treatments often fail to prevent relapses. New therapies targeting B cells, APRIL/BLyS, and complement pathways may reshape care in the years ahead. kidney.pub/JASN1283
UIC Transplant Pharmacotherapy Team retweeted
Fang et al. report a survival benefit of SLKT in patients with severe renal dysfunction, which disappeared after the 2017 OPTN policy, despite fewer SLKT procedures and unchanged survival.#TXPforAll #OpenAccess tinyurl.com/bzd7whry
The focused update of the KDIGO 2027 CKD Guideline is available for public review through November 4, 2026.
KDIGO invites the global kidney community to review the draft and share feedback to help inform and improve the final update.
Visit the KDIGO CKD Guideline website to download the draft and share your comments via the feedback survey:
kdigo.org/guidelines/ckd-eva…
The focused update addresses new evidence since publication of the KDIGO 2024 CKD Guideline on SGLT2 inhibitors, GLP-1-based therapies, and nsMRAs in people with CKD, excluding those receiving dialysis or who have received a kidney transplant.
Thank you for your time and insights.


































